Pegsunercept

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NamePegsunercept

Drug Alias NamePEG sTNF-R1PEG sTNF-RIPegylated soluble tumour necrosis factor receptor type IPegylated recombinant methionyl human soluble tumour necrosis factor receptor type 1

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionTumor necrosis factor inhibitors

TargetsTumor necrosis factor

Therapy Area/IndicationsArthritis, Rheumatoid

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAmgen Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAmgen Inc

Active IndicationsN/A

Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A